Kerndatensatz Senologie - Local Development build (v0.9.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

• Narrative Content
• JSON

: Fall 2: Studienteilnahme KEYNOTE-522 - JSON Representation

Raw json | Download

{
  "resourceType" : "ResearchSubject",
  "id" : "Fall2-Studienteilnahme",
  "meta" : {
    "profile" : [
      🔗 "https://www.senologie.org/fhir/StructureDefinition/senologie-studienteilnahme"
    ]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ResearchSubject Fall2-Studienteilnahme</b></p><a name=\"Fall2-Studienteilnahme\"> </a><a name=\"hcFall2-Studienteilnahme\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-senologie-studienteilnahme.html\">BIH Senologie Studienteilnahme</a></p></div><p><b>Screeningstatus</b>: <span title=\"Codes:{http://snomed.info/sct 1304144001}\">Eligible for clinical trial</span></p><p><b>Kontaktperson Studie</b>: Dr. med. Markus Weber, Studienzentrale Onkologie</p><p><b>Aufklärungsdatum</b>: 2025-02-25</p><p><b>status</b>: On-study-intervention</p><p><b>period</b>: 2025-03-01 --&gt; (ongoing)</p><p><b>study</b>: <a href=\"ResearchStudy-Fall2-ResearchStudy-KEYNOTE522.html\">KEYNOTE-522</a></p><p><b>individual</b>: <a href=\"Patient-Fall2-Patient-Lena-Hoffmann.html\">Lena Hoffmann</a></p><p><b>assignedArm</b>: Interventionsarm: Pembrolizumab + Chemotherapie</p><p><b>consent</b>: Studieneinwilligung KEYNOTE-522 vom 2025-02-25</p></div>"
  },
  "extension" : [
    {
      "url" : "https://www.senologie.org/fhir/StructureDefinition/ex-senologie-screeningstatus",
      "valueCodeableConcept" : {
        "coding" : [
          {
            "system" : "http://snomed.info/sct",
            "code" : "1304144001",
            "display" : "Eligible for clinical trial"
          }
        ]
      }
    },
    {
      "url" : "https://www.senologie.org/fhir/StructureDefinition/ex-senologie-studienkontakt",
      "valueString" : "Dr. med. Markus Weber, Studienzentrale Onkologie"
    },
    {
      "url" : "https://www.senologie.org/fhir/StructureDefinition/ex-senologie-aufklaerungsdatum",
      "valueDate" : "2025-02-25"
    }
  ],
  "status" : "on-study-intervention",
  "period" : {
    "start" : "2025-03-01"
  },
  "study" : {
    🔗 "reference" : "ResearchStudy/Fall2-ResearchStudy-KEYNOTE522",
    "display" : "KEYNOTE-522"
  },
  "individual" : {
    🔗 "reference" : "Patient/Fall2-Patient-Lena-Hoffmann",
    "display" : "Lena Hoffmann"
  },
  "assignedArm" : "Interventionsarm: Pembrolizumab + Chemotherapie",
  "consent" : {
    "display" : "Studieneinwilligung KEYNOTE-522 vom 2025-02-25"
  }
}